Clinical Study Evaluating the Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 65
Healthy Volunteers: f
View:
• Patients with mild to moderate disease activity.
• Patient age must be more than 18 years.
Locations
Other Locations
Egypt
Alexandria university hospital
RECRUITING
Alexandria
Contact Information
Primary
AHMED ABDELBAR, MSc
dr.ahmed_post@yahoo.com
00201021914588
Time Frame
Start Date: 2023-07-18
Estimated Completion Date: 2026-09
Participants
Target number of participants: 80
Treatments
Active_comparator: Intervention group
Diosmin 450 mg and Hesperidin 50 mg Combination /tablet/ twice daily for 3 months + Conventional Therapy (Methotrexate)
No_intervention: Control group
Conventional Therapy (Methotrexate) only
Related Therapeutic Areas
Sponsors
Leads: Alexandria University